DIRECTOR :
JAYANT JAGANNATH KHANDARE
As On :
Sunday, 24 November 2024
Total Page Views : 13 | Name | JAYANT JAGANNATH KHANDARE |
| Total Companies | 8 |
| First Appointment Date | Wednesday, 14 August 2013 |
| Last Resigned Date | |
| Social Links | |
JAYANT JAGANNATH KHANDARE was appointed on Wednesday, 14 August 2013 with ACTORIUS INNOVATIONS AND RESEARCH PRIVATE LIMITED - MUMBAI - Total Tenure of 11 Year(s), 3 month(s), 10 day(s), and also appointed on Wednesday, 10 September 2014 with RIGHT TO RESEARCH FOUNDATION - PUNE - Total Tenure of 10 Year(s), 2 month(s), 14 day(s), and also appointed on Friday, 10 July 2015 with SOLUTIONS IN INNOVATIVE RESEARCH PRIVATE LIMITED - PUNE - Total Tenure of 9 Year(s), 4 month(s), 14 day(s), and also appointed on Wednesday, 31 January 2018 with ORMECON PRIVATE LIMITED - MUMBAI - Total Tenure of 6 Year(s), 9 month(s), 24 day(s), and also appointed on Tuesday, 12 October 2021 with ADMATIUS INNOVATIONS PRIVATE LIMITED - PUNE - Total Tenure of 3 Year(s), 1 month(s), 12 day(s), and also appointed on Monday, 20 December 2021 with ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED - PUNE - Total Tenure of 2 Year(s), 11 month(s), 4 day(s), and also appointed on Monday, 14 March 2022 with CANVIN INNOVATION PRIVATE LIMITED - MUMBAI - Total Tenure of 2 Year(s), 8 month(s), 10 day(s), and also appointed on Thursday, 22 September 2022 with PRECISION ONCOLOGY FOUNDATION - PUNE - Total Tenure of 2 Year(s), 2 month(s), 2 day(s)
Dr. Jayant J. Khandare is the Managing Director (MD) and Chief Scientific Officer (CSO) of Actorius Innovations and Research Pvt Ltd. After earning his bachelor's and masters degree in Pharmacy. Jayant received a Ph.D. (Polymer Chemistry) in Chemical Engineering from the prestigious National Chemical Laboratory, Pune, in 2003. Post Ph.D., Jayant completed two postdoctoral tenures in the School of Medicine, Wayne State University, Detroit, MI, USA and the Dept. of Pharmaceutics, Rutgers, The State University, Piscataway, New Jersey, USA. He worked extensively on targeted nano polymeric drug delivery systems for Cancer. Jayant’s excellent work resulted in him being awarded the prestigious Alexander Von Humboldt Experienced Researcher Award and he worked for one year in Germany with Prof.Dr.Rainer Haag at Freie University, Berlin, Germany in the field of Macromolecular Chemistry. He then established and led the Polymer Chemistry Group at Piramal Life Sciences. Jayant has published more than 40 papers in peer-reviewed journals and has 14 US patents to his credit. Jayant brings to the table an eclectic mix of knowledge in subjects as diverse as pharmaceutics, chemical engineering, polymer chemistry and cancer biology. | Rank | Logo | CIN | Company Name | City | Appointed Date | Resign Date | Date of Incorporation | Status |
|---|
| 679137 |  | U73100MH2013PTC246961 | ACTORIUS INNOVATIONS AND RESEARCH PRIVATE LIMITED | MUMBAI | Wednesday, 14 August 2013 | | Wednesday, 14 August 2013 | |
| 1656797 |  | U74999PN2014NPL152466 | RIGHT TO RESEARCH FOUNDATION | PUNE | Wednesday, 10 September 2014 | | Wednesday, 10 September 2014 | |
| 1695163 | | U74900PN2015PTC155756 | SOLUTIONS IN INNOVATIVE RESEARCH PRIVATE LIMITED | PUNE | Friday, 10 July 2015 | | Friday, 10 July 2015 | |
| 832056 | | U74999MH2018PTC304736 | ORMECON PRIVATE LIMITED | MUMBAI | Wednesday, 31 January 2018 | | Wednesday, 31 January 2018 | |
| 2494091 | | U73100PN2021PTC205122 | ADMATIUS INNOVATIONS PRIVATE LIMITED | PUNE | Tuesday, 12 October 2021 | | Tuesday, 12 October 2021 | |
| 2524756 | | U85100PN2021PTC207038 | ONECELL DIAGNOSTICS INDIA PRIVATE LIMITED | PUNE | Monday, 20 December 2021 | | Monday, 20 December 2021 | |
| 2089414 | | U85320MH2018PTC313359 | CANVIN INNOVATION PRIVATE LIMITED | MUMBAI | Monday, 14 March 2022 | | Saturday, 01 September 2018 | |
| 2642338 | | U92490PN2022NPL214967 | PRECISION ONCOLOGY FOUNDATION | PUNE | Thursday, 22 September 2022 | | Thursday, 22 September 2022 | |
Suit Filed accounts of Rs. 25 Lacs and above Total Suit Filed : 0
| # | Category | Bank / FI | Branch | Outstanding Amount
In Lacs | Asset Classification | Date Of Classification | Suit |
|---|
Report Director Information Discrepancy
The information shown on this page was last updated onSunday, 24 November 2024
Due to frequent changes in Director Information, it is possible that some details you see may be out-of-date. If you feel the information is not up-to-date, you may request to get this page auto-updated now.
Request For Update If you still notice any discrepancy, please help by reporting it to us.
We appreciate your help!
Report Discrepancy 
